These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9161472)

  • 1. Possible monocytic origin of chondrosarcoma: in vitro transdifferentiation of HLA-DR blood monocyte-like cells from a patient with chondrosarcoma, into neo-fibroblasts and chondrocyte-like cells.
    Labat ML; Bringuier AF; Séébold-Choqueux C; Moricard Y; Meyer-Mula C; Delepine N; Delepine G; Desbois JC; Strauss P
    Biomed Pharmacother; 1997; 51(2):79-93. PubMed ID: 9161472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-lymphocyte control of HLA-DR blood monocyte differentiation into neo-fibroblasts. Further evidence of pluripotential secreting functions of HLA-DR monocytes, involving not only collagen but also uromodulin, amyloid-beta peptide, alpha-fetoprotein and carcinoembryonic antigen.
    Bringuier AF; Séébold-Choqueux C; Moricard Y; Simmons DJ; Milhaud G; Labat ML
    Biomed Pharmacother; 1992; 46(2-3):91-108. PubMed ID: 1384752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocytic origin of fibrosis. In vitro transformation of HLA-DR monocytes into neo-fibroblasts: inhibitory effect of all-trans retinoic acid on this process.
    Labat ML; Bringuier AF; Arys-Philippart C; Arys A; Wellens F
    Biomed Pharmacother; 1994; 48(2):103-11. PubMed ID: 7919103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis: production of high levels of uromodulin-like protein by HLA-DR blood monocytes differentiating towards a fibroblastic phenotype.
    Labat ML; Bringuier AF; Seebold-Choqueux C; Moricard Y; Rault G; Jehanne M; Ferrec C; Milhaud G
    Biomed Pharmacother; 1991; 45(9):387-401. PubMed ID: 1786344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocytic origin of fibroblasts: spontaneous transformation of blood monocytes into neo-fibroblastic structures in osteomyelosclerosis and Engelmann's disease.
    Labat ML; Bringuier AF; Séébold C; Moricard Y; Meyer-Mula C; Laporte P; Talmage RV; Grubb SA; Simmons DJ; Milhaud G
    Biomed Pharmacother; 1991; 45(7):289-99. PubMed ID: 1760520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the track of a human circulating mesenchymal stem cell of neural crest origin.
    Labat ML; Milhaud G; Pouchelet M; Boireau P
    Biomed Pharmacother; 2000 Apr; 54(3):146-62. PubMed ID: 10840592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of Blood Monocyte HLA-DR in ICU Patients Is Also Present in Bone Marrow Cells.
    Faivre V; Lukaszewicz AC; Payen D
    PLoS One; 2016; 11(11):e0164489. PubMed ID: 27893741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DR-mediated apoptosis susceptibility discriminates differentiation stages of dendritic/monocytic APC.
    Bertho N; Drénou B; Laupeze B; Berre CL; Amiot L; Grosset JM; Fardel O; Charron D; Mooney N; Fauchet R
    J Immunol; 2000 Mar; 164(5):2379-85. PubMed ID: 10679073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal photophoresis increases sensitivity of monocytes from patients with graft-versus-host disease to HLA-DR-mediated cell death.
    Setterblad N; Garban F; Weigl R; Assier E; Drillat P; Charron D; Dickinson A; Greinix H; Mooney N
    Transfusion; 2008 Jan; 48(1):169-77. PubMed ID: 17900279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR human histocompatibility leukocyte antigens-restricted lymphocyte-monocyte interactions in the release from monocytes of acidic isoferritins that suppress hematopoietic progenitor cells.
    Broxmeyer HE; Juliano L; Lu L; Platzer E; Dupont B
    J Clin Invest; 1984 Apr; 73(4):939-53. PubMed ID: 6231314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HLA-A,B,C, beta 2-microglobulin (beta 2m), HLA-DR, -DP, -DQ and of HLA-D-associated invariant chain (Ii) in soft-tissue tumors.
    Mechtersheimer G; Staudter M; Majdic O; Dörken B; Moldenhauer G; Möller P
    Int J Cancer; 1990 Nov; 46(5):813-23. PubMed ID: 2228310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HLA-DR-triggered monocytes mediate in vitro T cell anergy.
    Kriegel MA; Adam-Klages S; Gabler C; Blank N; Schiller M; Scheidig C; Kalden JR; Lorenz HM
    Int Immunol; 2008 Apr; 20(4):601-13. PubMed ID: 18310062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DR expression on monocytes is decreased in polytraumatized patients.
    Vester H; Dargatz P; Huber-Wagner S; Biberthaler P; van Griensven M
    Eur J Med Res; 2015 Oct; 20():84. PubMed ID: 26474862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low/-) monocytes in B-cell non-Hodgkin lymphoma.
    Xiu B; Lin Y; Grote DM; Ziesmer SC; Gustafson MP; Maas ML; Zhang Z; Dietz AB; Porrata LF; Novak AJ; Liang AB; Yang ZZ; Ansell SM
    Blood Cancer J; 2015 Jul; 5(7):e328. PubMed ID: 26230952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A circulating subpopulation of monocytic myeloid-derived suppressor cells as an independent prognostic/predictive factor in untreated non-small lung cancer patients.
    Vetsika EK; Koinis F; Gioulbasani M; Aggouraki D; Koutoulaki A; Skalidaki E; Mavroudis D; Georgoulias V; Kotsakis A
    J Immunol Res; 2014; 2014():659294. PubMed ID: 25436215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study.
    Döcke WD; Höflich C; Davis KA; Röttgers K; Meisel C; Kiefer P; Weber SU; Hedwig-Geissing M; Kreuzfelder E; Tschentscher P; Nebe T; Engel A; Monneret G; Spittler A; Schmolke K; Reinke P; Volk HD; Kunz D
    Clin Chem; 2005 Dec; 51(12):2341-7. PubMed ID: 16214828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major histocompatibility restriction of antigen recognition by T cells in a recipient of haplotype mismatched human bone marrow transplantation.
    Chu E; Umetsu D; Rosen F; Geha RS
    J Clin Invest; 1983 Sep; 72(3):1124-9. PubMed ID: 6193142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of monocyte/macrophage C2 production and HLA-DR expression by IL-4 (BSF-1) and IFN-gamma.
    Littman BH; Dastvan FF; Carlson PL; Sanders KM
    J Immunol; 1989 Jan; 142(2):520-5. PubMed ID: 2492049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional abolition of monocyte HLA-DR by aldehyde treatment. A novel approach to studies of class II restriction elements in antigen presentation.
    Rhodes J; Tite J
    J Immunol; 1988 May; 140(10):3344-51. PubMed ID: 3361123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by granulocyte-macrophage colony-stimulating factor and interferon-gamma in vitro.
    Kylanpaa ML; Mentula P; Kemppainen E; Puolakkainen P; Aittomaki S; Silvennoinen O; Haapiainen R; Repo H
    Pancreas; 2005 Jul; 31(1):23-7. PubMed ID: 15968243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.